Zijin Mining Shares Hit Record High on $4 Billion Allied Gold Acquisition 
Micron to Expand Memory Chip Manufacturing Capacity in Singapore Amid Global Shortage 
Shell Plc Downgraded by RBC as Market Headwinds Pressure Valuation 
LVMH Investors Watch Earnings Closely as Luxury Recovery Faces New Challenges 
Citigroup Faces Lawsuit Over Alleged Sexual Harassment by Top Wealth Executive 
Samsung Set to Begin HBM4 Production for Nvidia and AMD 
Ryanair Profit Slumps in Q3 After Italy Antitrust Fine Despite Revenue Growth 
ASML’s EUV Monopoly Powers the Global AI Chip Boom 
Hermès Menswear Marks Historic Transition as Véronique Nichanian Bids Farewell in Paris 
Hyundai Motor Shares Slide After Trump Signals Higher U.S. Tariffs on South Korean Goods 
ANTA Sports to Acquire Major Stake in Puma in €1.5 Billion Deal, Signaling Strategic Revival 
BYD and Exxon Mobil Strengthen Hybrid Technology Partnership 
Delta Air Lines Operates Reduced Flight Schedule as Winter Storm Disrupts U.S. Travel 
Trump Administration Takes Stake in USA Rare Earth to Boost U.S. Critical Minerals Supply 
Microsoft Wins Approval to Build 15 New Data Centers in Wisconsin 
SAN FRANCISCO, May 16, 2017 -- BioQ Pharma Incorporated, a specialty pharmaceutical company, announced today that the Company will be presenting at the UBS Global Healthcare Conference to be held in New York City from May 22nd to May 24th, 2017.
Josh Kriesel, President and Chief Executive Officer, is scheduled to present on Tuesday, May 23rd at 2:00 p.m. Eastern Daylight Time.
About BioQ Pharma
BioQ Pharma Incorporated is a privately held specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals. The Company's infusion platform is intended to address some of the most pressing unmet needs in drug infusion today: cost, medication error, sterility, efficiency, and patient quality of life. BioQ Pharma's vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via the Company's proprietary unit-dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. The Company is ISO13485 certified. BioQ Pharma's commercial collaborators and strategic partners include Novartis' Sandoz unit, Cipla, Lee's Pharm, Lunatus, Galen Limited, and West Pharmaceutical Services.
BioQ Pharma Contact Information: Josh Kriesel President and CEO 415-336-6496 Ron Pauli Chief Financial Officer 415-889-7707 Media: Stephanie Carrington Integrated Corporate Relations, Inc (ICR) [email protected] 646-277-1282
